Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 6;13(1):e70092.
doi: 10.1002/ccr3.70092. eCollection 2025 Jan.

Complications of Mesenteric Vein Thrombosis: Heterozygous Factor V Leiden Mutation Leads to Pulmonary Embolism in a Patient With Post-Bowel Resection Surgery

Hafiz Muhammad Hamza  1 , Muhammad Muiz Malik  1 , Ayaz Ahmed Awan  1 , Muhammad Daoud Tariq  1 , Mohamed Daoud  2 , Aman Goyal  3
Affiliations

Complications of Mesenteric Vein Thrombosis: Heterozygous Factor V Leiden Mutation Leads to Pulmonary Embolism in a Patient With Post-Bowel Resection Surgery

Hafiz Muhammad Hamza et al. Clin Case Rep. .

Abstract

It is critical to recognize pulmonary embolism as soon as possible in patients who have gastrointestinal problems pre- and post-surgery. Even in the absence of conventional risk factors, the Factor V Leiden mutation emphasizes the importance of a thorough thrombophilia assessment. To effectively manage and prevent thrombotic episodes, prompt anticoagulant medication and genetic screening for family members are essential.

Keywords: Leiden mutation; bowel resection; factor V; mesenteric vein; pulmonary embolism.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Visualization of ileostomy in CTPA imaging.
FIGURE 2
FIGURE 2
Visualization of left pulmonary arteries in CTPA imaging.
FIGURE 3
FIGURE 3
Visualization of the main pulmonary trunk in CTPA imaging.
FIGURE 4
FIGURE 4
Visualization of the right pulmonary artery in CTPA imaging.
See this image and copyright information in PMC

References

    1. Fernandez M. M., Hogue S., Preblick R., and Kwong W. J., “Review of the Cost of Venous Thromboembolism,” ClinicoEconomics and Outcomes Research 7 (2015): 451–462, 10.2147/CEOR.S85635. - DOI - PMC - PubMed
    1. El Marraki Z., Bouzhir A., Eddhima Z., El Bouanani A. E., Mouine N., and Benyass A., “Homozygous Factor V Leiden Mutation: Rare Etiology of Pulmonary Embolism,” Annals of Medicine and Surgery (London) 82 (2022): 104569, 10.1016/j.amsu.2022.104569. - DOI - PMC - PubMed
    1. De Pablo‐Moreno J. A., Miguel‐Batuecas A., de Sancha M., and Liras A., “The Magic of Proteases: From a Procoagulant and Anticoagulant Factor V to an Equitable Treatment of Its Inherited Deficiency,” International Journal of Molecular Sciences 24, no. 7 (2023): 6243, 10.3390/ijms24076243. - DOI - PMC - PubMed
    1. Hmoud B., Singal A. K., and Kamath P. S., “Mesenteric Venous Thrombosis,” Journal of Clinical and Experimental Hepatology 4, no. 3 (2014): 257–263, 10.1016/j.jceh.2014.03.052. - DOI - PMC - PubMed
    1. Al‐Otaiby M., Althnayan R., Binmethem A., et al., “The Prevalence of Factor V Leiden (Arg506Gln) Mutation in King Khalid University Hospital Patients, 2017‐2019,” Nagoya Journal of Medical Science 83, no. 3 (2021): 407–417, 10.18999/nagjms.83.3.407. - DOI - PMC - PubMed

LinkOut - more resources